Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             120 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults Lyons, Arthur
 2008
 26 Supplement 4 p. 2890-2898
9 p.
 artikel
2 Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998–2004 Sebastian, R.
 2008
 26 Supplement 4 p. 1397-1403
7 p.
 artikel
3 Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells Glück, Joanna
 2007
 26 Supplement 4 p. 77-81
5 p.
 artikel
4 Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2 Svane, Inge Marie
 2008
 26 Supplement 4 p. 4716-4724
9 p.
 artikel
5 Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection Bungener, Laura
 2008
 26 Supplement 4 p. 2350-2359
10 p.
 artikel
6 Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines Verstraeten, Thomas
 2008
 26 Supplement 4 p. 6630-6638
9 p.
 artikel
7 Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results Dhiman, Neelam
 2008
 26 Supplement 4 p. 1731-1736
6 p.
 artikel
8 Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule Calarota, Sandra A.
 2008
 26 Supplement 4 p. 3121-3134
14 p.
 artikel
9 A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses Sohn, Young Mo
 2008
 26 Supplement 4 p. 1638-1643
6 p.
 artikel
10 Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula) Walcher, Petra
 2008
 26 Supplement 4 p. 6832-6838
7 p.
 artikel
11 Bath vaccination of rainbow trout (Oncorhynchus mykiss Walbaum) against Yersinia ruckeri: Effects of temperature on protection and gene expression Raida, M.K.
 2008
 26 Supplement 4 p. 1050-1062
13 p.
 artikel
12 c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection Ogunniyi, Abiodun D.
 2008
 26 Supplement 4 p. 4676-4685
10 p.
 artikel
13 Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects Guy, Bruno
 2008
 26 Supplement 4 p. 5712-5721
10 p.
 artikel
14 Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen Mutwiri, George
 2008
 26 Supplement 4 p. 2680-2688
9 p.
 artikel
15 Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity Hamdy, Samar
 2008
 26 Supplement 4 p. 5046-5057
12 p.
 artikel
16 Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants Gatchalian, Salvacion
 2008
 26 Supplement 4 p. 2234-2241
8 p.
 artikel
17 Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum Xie, Yong
 2008
 26 Supplement 4 p. 3452-3460
9 p.
 artikel
18 Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073 Fytili, P.
 2008
 26 Supplement 4 p. 3818-3826
9 p.
 artikel
19 Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses Huang, Jen-Min
 2008
 26 Supplement 4 p. 6043-6052
10 p.
 artikel
20 Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4 Blaney Jr., Joseph E.
 2008
 26 Supplement 4 p. 817-828
12 p.
 artikel
21 Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination Rieber, Nikolaus
 2008
 26 Supplement 4 p. 6929-6935
7 p.
 artikel
22 DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo Da’Dara, Akram A.
 2008
 26 Supplement 4 p. 3617-3625
9 p.
 artikel
23 Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD Donofrio, G.
 2008
 26 Supplement 4 p. 6031-6042
12 p.
 artikel
24 Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia Shefer, Abigail
 2008
 26 Supplement 4 p. K68-K75
nvt p.
 artikel
25 Editorial Board 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
26 Editorial Board 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
27 Editorial Board 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
28 Editorial Board 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
29 Editorial Board 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
30 Editorial Board 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
31 Editorial Board 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
32 Editorial Board 2007
 26 Supplement 4 p. CO2-
1 p.
 artikel
33 Editorial Board/Aims and Scope 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
34 Editorial Board/Aims and Scope 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
35 Editorial Board/Aims and Scope 2008
 26 Supplement 4 p. CO2-
1 p.
 artikel
36 Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant Cataldi, Angel
 2008
 26 Supplement 4 p. 5662-5667
6 p.
 artikel
37 Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990–2006 Chang, Soju
 2008
 26 Supplement 4 p. 2428-2432
5 p.
 artikel
38 Emergency vaccination of sheep against foot-and-mouth disease: Significance and detection of subsequent sub-clinical infection Parida, S.
 2008
 26 Supplement 4 p. 3469-3479
11 p.
 artikel
39 Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice Wei, Feng
 2008
 26 Supplement 4 p. 4145-4149
5 p.
 artikel
40 Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin Boberg, A.
 2008
 26 Supplement 4 p. 5079-5082
4 p.
 artikel
41 European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations Giammanco, Anna
 2008
 26 Supplement 4 p. 4486-4493
8 p.
 artikel
42 Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys Blaney Jr., Joseph E.
 2008
 26 Supplement 4 p. 4150-4159
10 p.
 artikel
43 Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers Wright, Peter F.
 2008
 26 Supplement 4 p. 882-890
9 p.
 artikel
44 Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals von Teichman, Beate F.
 2008
 26 Supplement 4 p. 5014-5021
8 p.
 artikel
45 Evaluation of the potential of synthetic peptides of 80kDa human sperm antigen (80kDaHSA) for the development of contraceptive vaccine for male Khobarekar, Bharati Gangaram
 2008
 26 Supplement 4 p. 3711-3718
8 p.
 artikel
46 Evaluation of widely consumed botanicals as immunological adjuvants Ragupathi, Govind
 2008
 26 Supplement 4 p. 4860-4865
6 p.
 artikel
47 EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium Bart, Pierre-Alexandre
 2008
 26 Supplement 4 p. 3153-3161
9 p.
 artikel
48 EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone McCormack, Sheena
 2008
 26 Supplement 4 p. 3162-3174
13 p.
 artikel
49 Expression and purification of a Plasmodium vivax antigen – PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjects Siddiqui, Asim A.
 2007
 26 Supplement 4 p. 96-107
12 p.
 artikel
50 Functional differences between M cells and enterocytes in sampling luminal antigens Kyd, Jennelle M.
 2008
 26 Supplement 4 p. 6221-6224
4 p.
 artikel
51 Gender-specific effects of cytokine gene polymorphisms on childhood vaccine responses Baynam, Gareth
 2008
 26 Supplement 4 p. 3574-3579
6 p.
 artikel
52 “Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation Edelman, Robert
 2008
 26 Supplement 4 p. 4113-4119
7 p.
 artikel
53 Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response Ramos, I.
 2008
 26 Supplement 4 p. 333-344
12 p.
 artikel
54 High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74) Alam, Mohammad Tauqeer
 2008
 26 Supplement 4 p. 3787-3794
8 p.
 artikel
55 HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response Starodubova, Elizaveta S.
 2008
 26 Supplement 4 p. 5170-5176
7 p.
 artikel
56 IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: Implications for its use as oral carrier vaccine Blanco, Helga M.
 2008
 26 Supplement 4 p. 6497-6502
6 p.
 artikel
57 Immune responses in mice to Mycobacterium avium subsp. paratuberculosis following vaccination with a novel 74F recombinant polyprotein Chen, Li-Hsuen
 2008
 26 Supplement 4 p. 1253-1262
10 p.
 artikel
58 Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus Li, Peng
 2008
 26 Supplement 4 p. 5802-5807
6 p.
 artikel
59 Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge Chung, Yao-Chi
 2008
 26 Supplement 4 p. 1855-1862
8 p.
 artikel
60 Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6–9 and 10–13 years Schmidt-Ott, Ruprecht
 2007
 26 Supplement 4 p. 32-40
9 p.
 artikel
61 Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial Jiang, Wei-Ping
 2008
 26 Supplement 4 p. 2297-2301
5 p.
 artikel
62 Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia Saaka, M.
 2008
 26 Supplement 4 p. 3719-3726
8 p.
 artikel
63 Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population Leach, Amanda J.
 2008
 26 Supplement 4 p. 3885-3891
7 p.
 artikel
64 Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice Babu, J. Pradeep
 2008
 26 Supplement 4 p. 4655-4663
9 p.
 artikel
65 Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles Lalitha, P.V.
 2008
 26 Supplement 4 p. 4526-4535
10 p.
 artikel
66 Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis Carrillo, Eugenia
 2008
 26 Supplement 4 p. 1902-1911
10 p.
 artikel
67 Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants Olivier, C.
 2008
 26 Supplement 4 p. 3142-3152
11 p.
 artikel
68 Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams Muñoz, Pilar-María
 2008
 26 Supplement 4 p. 2562-2569
8 p.
 artikel
69 Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program? Kwong, Jeffrey C.
 2008
 26 Supplement 4 p. 6006-6012
7 p.
 artikel
70 Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults Chen, Meng
 2008
 26 Supplement 4 p. 4962-4968
7 p.
 artikel
71 Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus Li, Xiangmin
 2008
 26 Supplement 4 p. 2714-2722
9 p.
 artikel
72 Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement Andrus, Jon Kim
 2008
 26 Supplement 4 p. K87-K92
nvt p.
 artikel
73 In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets Linghua, Zhang
 2008
 26 Supplement 4 p. 224-233
10 p.
 artikel
74 Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine Fei-fei, Ge
 2008
 26 Supplement 4 p. 5590-5594
5 p.
 artikel
75 Lipid A and liposomes containing lipid A as antigens and adjuvants Alving, Carl R.
 2008
 26 Supplement 4 p. 3036-3045
10 p.
 artikel
76 Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine Airhart, Christina L.
 2008
 26 Supplement 4 p. 5554-5561
8 p.
 artikel
77 Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age Poovorawan, Yong
 2008
 26 Supplement 4 p. 1535-1540
6 p.
 artikel
78 Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers Littmann, Martina
 2008
 26 Supplement 4 p. 2344-2349
6 p.
 artikel
79 Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization Gudmundsdotter, Lindvi
 2008
 26 Supplement 4 p. 5107-5110
4 p.
 artikel
80 Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals Lima-Junior, J.C.
 2008
 26 Supplement 4 p. 6645-6654
10 p.
 artikel
81 Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures Jäkel, Anne
 2008
 26 Supplement 4 p. 6655-6663
9 p.
 artikel
82 Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine Arrode, Geraldine
 2008
 26 Supplement 4 p. 3795-3804
10 p.
 artikel
83 Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates Fine, Donald L.
 2008
 26 Supplement 4 p. 3497-3506
10 p.
 artikel
84 Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2 Zhang, Hong-Ying
 2008
 26 Supplement 4 p. 769-777
9 p.
 artikel
85 Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries Cuzick, Jack
 2008
 26 Supplement 4 p. K29-K41
nvt p.
 artikel
86 pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection Malheiro, Adriana
 2008
 26 Supplement 4 p. 305-315
11 p.
 artikel
87 Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers Sadorge, Christine
 2008
 26 Supplement 4 p. 978-987
10 p.
 artikel
88 Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study Pialoux, Gilles
 2008
 26 Supplement 4 p. 2657-2666
10 p.
 artikel
89 Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage Erdem, Hakan
 2008
 26 Supplement 4 p. 1271-1273
3 p.
 artikel
90 Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination Helson, Rebecca
 2008
 26 Supplement 4 p. 753-761
9 p.
 artikel
91 Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production Elias, Daniel
 2008
 26 Supplement 4 p. 3897-3902
6 p.
 artikel
92 Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice Qu, Daofeng
 2008
 26 Supplement 4 p. 4541-4548
8 p.
 artikel
93 Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle Chang, Byoung Sun
 2008
 26 Supplement 4 p. 2081-2091
11 p.
 artikel
94 Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser) Jarvi, Susan I.
 2008
 26 Supplement 4 p. 5338-5344
7 p.
 artikel
95 Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica Herrero, Rolando
 2008
 26 Supplement 4 p. 4795-4808
14 p.
 artikel
96 Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice Xu, Juan
 2008
 26 Supplement 4 p. 4519-4525
7 p.
 artikel
97 Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children Esteghamati, Abdoulreza
 2008
 26 Supplement 4 p. 5058-5061
4 p.
 artikel
98 Report of the third meeting on “Influenza vaccines that induce broad spectrum and long-lasting immune responses”, World Health Organization, Geneva, Switzerland, 3–4 December 2007 Girard, Marc P.
 2008
 26 Supplement 4 p. 2443-2450
8 p.
 artikel
99 Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants Li, Rong Cheng
 2008
 26 Supplement 4 p. 2260-2269
10 p.
 artikel
100 Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses Sigurdardottir, Sigurveig Th.
 2008
 26 Supplement 4 p. 4178-4186
9 p.
 artikel
101 Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China Zhu, Feng Cai
 2008
 26 Supplement 4 p. 4579-4584
6 p.
 artikel
102 Safety evaluation of a canine hepatitis DNA vaccine Liu, Fu Ying
 2008
 26 Supplement 4 p. 6925-6928
4 p.
 artikel
103 Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial Sacarlal, Jahit
 2008
 26 Supplement 4 p. 174-184
11 p.
 artikel
104 Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines Prymula, Roman
 2008
 26 Supplement 4 p. 4563-4570
8 p.
 artikel
105 Seroepidemiology as basis for design of a human papillomavirus vaccination program Ryding, J.
 2008
 26 Supplement 4 p. 5263-5268
6 p.
 artikel
106 Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel Singer, Darrell E.
 2008
 26 Supplement 4 p. 869-873
5 p.
 artikel
107 Sexual dimorphism of humoral immunity with human vaccines Cook, Ian Francis
 2008
 26 Supplement 4 p. 3551-3555
5 p.
 artikel
108 Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age Block, Stan L.
 2008
 26 Supplement 4 p. 4940-4946
7 p.
 artikel
109 Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine Gelinck, L.B.S.
 2008
 26 Supplement 4 p. 3528-3533
6 p.
 artikel
110 The antifertility effects of DNA vaccine-induced immune responses against uroguanylin Sun, Jing
 2008
 26 Supplement 4 p. 3696-3704
9 p.
 artikel
111 The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the Netherlands Goossens, Lucas M.A.
 2008
 26 Supplement 4 p. 1118-1127
10 p.
 artikel
112 The effect of oral administration of a homologous hilA mutant strain on the long-term colonization and transmission of Salmonella Enteritidis in broiler chickens Bohez, Lotte
 2008
 26 Supplement 4 p. 372-378
7 p.
 artikel
113 The effects of IL-6 and TNF-α as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination Su, Baowei
 2008
 26 Supplement 4 p. 5111-5122
12 p.
 artikel
114 The epidemiology of mumps in Italy Gabutti, G.
 2008
 26 Supplement 4 p. 2906-2911
6 p.
 artikel
115 The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant Liu, Xiuping
 2008
 26 Supplement 4 p. 786-796
11 p.
 artikel
116 The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand Stehr-Green, Paul
 2008
 26 Supplement 4 p. 739-742
4 p.
 artikel
117 Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals Clements, C. John
 2008
 26 Supplement 4 p. 1926-1933
8 p.
 artikel
118 Vaccination of broiler chickens with dispersed dry powder vaccines as an alternative for liquid spray and aerosol vaccination Corbanie, E.A.
 2008
 26 Supplement 4 p. 4469-4476
8 p.
 artikel
119 Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers Vandepapelière, Pierre
 2008
 26 Supplement 4 p. 1375-1386
12 p.
 artikel
120 Vitamin A supplements are well tolerated with the pentavalent vaccine Newton, Sam
 2008
 26 Supplement 4 p. 6608-6613
6 p.
 artikel
                             120 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland